Literature DB >> 7691935

Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes.

U Dianzani1, V Redoglia, M Bragardo, C Attisano, A Bianchi, D Di Franco, U Ramenghi, H Wolff, L F Thompson, A Pileri.   

Abstract

CD73 is a molecule expressed by a subset of CD8+ human T lymphocytes and is involved in T cell activation. CD73 expression and function were analyzed in peripheral blood CD45RAhiCD45ROlo (naive) and CD45RAloCD45ROhi (memory) CD8+ cells. We found that CD73 was expressed by a majority of naive cells (74 +/- 12%), whereas fewer memory cells were CD73+ (29 +/- 10%). Moreover, CD73 was selectively expressed by the CD11b- subset of naive CD8+ cells, which were almost all CD73+. The same result was found on CD8+ cord blood lymphocytes, which prevalently display the naive phenotype. Naive CD8+ CD11b- cells were almost unresponsive to CD3 engagement, but this apparent anergy was completely overcome when CD3 and CD73 were simultaneously cross-linked by plastic-immobilized CD73 and CD3 mAb, showing that CD73 delivers an accessory signal that allows their activation via the CD3/TCR. This costimulatory signal was tenfold more potent than that induced by CD28 ligation. A phosphotyrosine analysis by Western blotting showed that cross-linking of CD73 induced the phosphorylation of two proteins with a molecular mass of approximately 28 and 100 kDa respectively, whereas ligation of CD3 induced phosphorylation of many substrates. When CD3 and CD73 were simultaneously triggered these substrates were hypophosphorylated. Because CD73 is linked to the cell surface by a GPI anchor, the transduction of this signal is probably mediated by a lateral interaction with transmembrane molecules. This hypothesis was assessed by cocapping, which showed that CD73 associates strongly with CD45RC, moderately with CD8, and weakly with CD3. These data suggest that CD73 signaling is coupled to both tyrosine kinase and phosphatase activities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691935

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.

Authors:  Masahide Takedachi; Dongfeng Qu; Yukihiko Ebisuno; Hiroyuki Oohara; Michelle L Joachims; Stephanie T McGee; Emiko Maeda; Rodger P McEver; Toshiyuki Tanaka; Masayuki Miyasaka; Shinya Murakami; Thomas Krahn; Michael R Blackburn; Linda F Thompson
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 2.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

Authors:  Marquet Minor; Karel P Alcedo; Rachel A Battaglia; Natasha T Snider
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

3.  CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.

Authors:  Dachuan Jin; Jie Fan; Long Wang; Linda F Thompson; Aijie Liu; Benjamin J Daniel; Tahiro Shin; Tyler J Curiel; Bin Zhang
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

Review 4.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

5.  Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.

Authors:  Siddharth V Rajakumar; Bo Lu; Sandra Crikis; Simon C Robson; Anthony J F d'Apice; Peter J Cowan; Karen M Dwyer
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

Review 6.  The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.

Authors:  Meihong Da; Luxia Chen; Alexander Enk; Sabine Ring; Karsten Mahnke
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

7.  Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells.

Authors:  L Airas; J Niemelä; M Salmi; T Puurunen; D J Smith; S Jalkanen
Journal:  J Cell Biol       Date:  1997-01-27       Impact factor: 10.539

8.  Circulating Factors in Trauma Plasma Activate Specific Human Immune Cell Subsets.

Authors:  Laura A Cahill; Fei Guo; Jennifer Nguyen; Fan Zhang; Anupamaa Seshadri; Joshua Keegan; Carl J Hauser; Leo E Otterbein; Simon Robson; Shahzad Shaefi; Michael B Yaffe; James A Lederer
Journal:  Injury       Date:  2020-03-04       Impact factor: 2.586

Review 9.  Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut.

Authors:  Maria Serena Longhi; Lili Feng; Simon C Robson
Journal:  Biochem Pharmacol       Date:  2021-01-15       Impact factor: 5.858

10.  High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma.

Authors:  Ya-Ping Xu; Ying-Qun Zhou; Yu-Jie Zhao; Yan Zhao; Feng Wang; Xiao-Yong Huang; Chuan-Yong Guo
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.